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Endothelium-derived NO is known to be the most potent endogenous vasodilator in the body. It is synthesised and released by the endothelium in response to a wide range of chemical, physical and humoral stimuli including thrombin, hormones, local autacoids, alterations in oxygen tension and shear stress [29, 30] . After synthesis NO is released into the subendothelial space and vascular lumen where it directly causes the underlying vascular smooth muscle to relax by binding to the heme moiety of soluble guanylate cyclase, thereby increasing the production of intracellular cyclic 3'-5'-guanosine monophosphate (cGMP) [31] [ Fig. 1 ]. Endothelial secretion of NO counterbalances the direct vasoconstrictive effects of norepinephrine, serotonin, angiotensin II and endothelin on the vascular smooth muscle [32] .
NO has also been shown to reduce oxygen consumption [33] and plays a critical role in the pathogenesis of atherosclerosis due to its inhibitory effects on platelet aggregation [34] , leukocyte adhesion [35] , DNA synthesis [36] and vascular smooth muscle cell proliferation [37] . In addition to its roles mentioned above, NO plays a significant role in the regulation of blood pressure. Indeed, NOS3 gene knock out mice develop severe hypertension and blood vessels isolated from these mice do not relax when exposed to endothelium-derived vasodilators such as acetylcholine [38] . It has also been shown that the inhibition of NO synthesis leads to significant peripheral vasoconstriction and elevation of blood pressure [39, 40] [ Table 1 ].
Oxidative Stress in Diabetes
The term oxidative stress refers to a condition in which cells are subjected to excessive levels of molecular oxygen or its chemical derivatives called reactive oxygen species (ROS).
Under physiological conditions, the molecular oxygen undergoes a series of reactions that ultimately lead to the generation of superoxide anion (O 2 -), hydrogen peroxide (H 2 O 2 ) and H 2 O. Peroxynitrite (OONO -), hypochlorus acid (HOCl), the hydroxyl radical (OH . ), reactive aldehydes, lipid peroxides and nitrogen oxides are considered among the other oxidants that have relevance to vascular biology. In the vascular endothelium, increases in oxidant stress may arise due to several mechanisms [ Table 2 ] and are associated with alterations in normal endothelial functions and are implicated in the pathogenesis of vascular complications in several disease states including diabetes mellitus (DM). However, the mechanisms underlying altered endothelium-dependent vascular relaxation in diabetes mellitus have been proposed to be multifactorial and seem to be dependent on the duration of hyperglycaemic state and vascular bed being studied. On the other hand, endothelial cells grown under hyperglycaemic conditions show decreased proliferation and fibrinolytic potential [94] and increased programmed cell death [95] .
Cellular mechanisms for the development of diabetic endothelial dysfunction
Non-enzymatic glycation
Another mechanism that may account for hyperglycaemia-derived vascular cell dysfunction is the spontaneous formation of glucose adducts to basic amino acids [lysine and arginine] and other amine-containing molecules. Although these early non-enzymatic glycation products are reversible (like glycohaemoglobin), they later become irreversibly modified products of glucose called "advanced glycation end-products" or AGEs, via slow and complex processes including glycation, glycooxidation and auto-oxidative glycosylation [96] .
Endothelial cells express receptors for AGEs [97] which facilitate their internalisation and transfer into the subendothelial space. AGEs may impair endothelium-dependent relaxation through glycosylation and oxidative modification of LDL which in turn directly inactivates or disrupts the formation of NO [98] . AGE induced modification of LDL also decreases the particle clearance [99] from the circulation thereby contributing to an expansion in LDL into endothelial cells.
Hyperglycaemia
Support for the concept of increased oxidative stress-mediated endothelial dysfunction in diabetes has derived from both in vitro and in vivo experiments which have suggested that hyperglycaemia is almost certainly the primary causal factor, mediated through several mechanisms, including alterations in the cellular redox state by an altered NADH/NAD + ratio, changes in the regulation of protein tyrosine kinases, dysregulation of protein kinase C and the accumulation of sorbitol.
Hyperglycaemia elicits an increase in the intracellular NADH/NAD + and a decrease in NADPH/NADP + ratios through hyperactivity of the sorbitol (polyol) pathway leading to a cytosolic redox imbalance i.e. hyperglycaemic pseudohypoxia [100] . This is so called due to The cellular NADPH pool required for NO generation and to replenish antioxidant glutathione may also be depleted in diabetes by a hyperactive pentose phosphate pathway activity in endothelial cells [108] , consequently leading to abnormalities in protein tyrosine kinase activation [109] . Activation of transcription factors by phosphorylation of tyrosine kinase plays significant roles in gene regulation of vascular cells to increase the production of extracellular matrix components discussed above.
Hyperglycaemia also alters several biochemical pathways including eicosanoids, protein kinase C (pKC) activity, long-chain fatty acids and ROS. Activation of several transcription factors by ROS plays a pivotal role in gene regulation and gene expression of vascular cells.
Increased cellular uptake of glucose stimulates pKC activity which mediates endothelial and vascular smooth muscle cell functions through regulation of permeability, contractility, blood flow and basement membrane synthesis and has therefore been associated with several vascular abnormalities. pKC can modulate the actions of hormones, growth factors and ion channels such as the Na/proton antiport, a key regulator of intracellular pH, growth, differentiation and contractility. pKC activation in diabetes has been implicated in the increases in intracellular diacylglycerol through either de novo synthesis via increased glycolysis or membrane-associated phosphatidyl inositol 4,5-biphosphate. In a rodent model of insulin dependent diabetes mellitus an oral inhibitor of the pKC isoforms ameliorated vascular dysfunction. pKC activity in addition to its aforementioned effects also activates peroxidase enzymes and the cyclooxygenase pathway thus causing overproduction of oxidative molecules [110] [111] [112] .
Hyperglycaemia is also linked with the activation of coagulation system through its connections with some of the aforementioned mechanisms namely non-enzymatic glycation and AGE formation which may decrease antithrombin III activity and increase tissue factor activity respectively as well as increased oxidative stress [113] [114] [115] . It is highly likely that during later stages of diabetes loss of endothelial anticoagulant properties may further activate coagulation cascade. Higher levels of a number of coagulation factors such as endotheliumderived von Willebrand's factor, fibrinogen and PAI-1, in association with endothelial cell damage and micro-and macrovascular damage may also contribute to this procoagulant state [116] [117] [118] .
Prevention and reversal of diabetic endothelial dysfunction
The close link between hyperglycaemia and endothelial dysfunction is supported by [120] . Similar studies have also suggested a prominent role for H 4 B availability in the regulation of NO production by diabetic endothelium, because 6-methyl-5,6,7,8-tetrahydrobiopterin improved the impaired endothelium-dependent vasodilatation in some vascular beds of diabetic animals [121] .
Antioxidant defences may also be impaired in diabetes thereby contributing to net oxidative stress [122] . Indeed a variety of defects in serum antioxidant status has been reported in diabetic patients compared to healthy subjects [123, 124] . Hence it has consequently been suggested that diabetic patients might benefit from supplementation with antioxidant vitamins (vitamin C and vitamin E) to prevent free radical oxidation and endothelial dysfunction as a result [125] . Vitamin C deficiency in diabetes may occur as a result of excessive excretion or poor diet. An increased oxidation of vitamin C as a result of increased free radical synthesis [126] and hence increased generation of its oxidation product, dehydroascorbic acid (DHA) [127] or a decline in the regeneration of vitamin C from DHA may largely be responsible for this deficiency. The latter may be due to competitive inhibition of vitamin C transport across the cell membrane via structurally similar glucose [128] . A consistent beneficial effect of vitamin C has been reported in human subjects and several animal models of human diseases.
Acute intra-arterial administration of vitamin C to patients with diabetes improves endothelium-dependent vasodilatation to methacholine but not the response to sodium nitroprusside, a NO donor or to a smooth muscle relaxant [129] . Similarly, physiological concentrations of vitamin C has been shown to reverse endothelial dysfunction in conduit arteries of patients with congestive heart failure [130] and angina [131] while intra-arterial infusion of supraphysiological concentrations of vitamin C has improved microvascular function in patients with hypertension and hypercholesterolaemia [132] . A recent report has also shown that vitamin C plays a significant role in the prevention of ROS production by scavenging O 2 -and apoptosis in the early stages of incubation of endothelial cells with high glucose [133] . The protective effects of antioxidants vitamin C and taurine have also been recently reported on renal injury in streptozotocin-induced diabetic rats in that these agents reduced albuminuria, glomerular hypertrophy, glomerular collagen and TGF-1 accumulation [134] . Administration of vitamin E has also been shown to have similar effects to these antioxidants in the early phase of glomerular injury. However, studies of chronic treatment with vitamin E are still needed as chronic dietary supplementation of vitamin E to diabetic rats has been attended with higher mortality rates [135] .
It is difficult to understand how vitamin C can act as an effective antioxidant in high risk (and high oxidative stress) patients considering very slow reaction rate between vitamin C and O 2 -compared to NO and O 2 - [136] . However, recent studies have suggested that vitamin C may improve the bioavailability of NO by regulating cellular redox state and also sparing intracellular glutathione from oxidation which may be important for NO in humans [137, 138] .
Vitamin E is the major lipid-soluble antioxidant, taken up by low-density lipoprotein (LDL) particles, which may improve endothelial function. Indeed, vitamin E supplements reduce the sensitivity of LDL to in vitro oxidation in healthy subjects as well as Type 2 diabetics [139] which suggests that endothelial function may be improved due to a reduction in the availability of oxidised LDL in diabetic vessels [140] . Vitamin E in addition inhibits glucose-induced protein kinase C  II activation in vascular smooth muscle cells [141] . Protein kinase C  II induction has been implicated in vasoconstrictive effects of several hormones such as angiotensin II [111] . It has been shown in animal models of diabetes that vitamin E treatment improves coronary and aortic vascular endothelial function and prevents diabetesinduced abnormalities [142, 143] although the opposite has been reported in mesenteric arterioles [144] . In contrast to the consistent beneficial effects observed in animal models, the results in humans have been mixed. One randomised study, the Cambridge Heart Antioxidant Study (CHAOS), demonstrated a marked reduction in non-fatal myocardial infarction in patients randomised to treatment with 400-800 IU of vitamin E/day compared to patients receiving placebo [145] . However, many subsequent studies including the Heart Outcomes Prevention Evaluation (HOPE) have failed to confirm these findings and revealed no beneficial effect of vitamin E on the prevention of cardiovascular disease after 4.5 years of use [146] .
The species differences and the phase of the disease may account for different results obtained from animal and human studies. Indeed, majority of the experimental studies investigated the bioavaliability of endothelium-derived NO or endothelium-derived vascular relaxation following treatment with vitamin E alone or in combination with vitamin C or -carotene imminently after the onset of diabetes following streptozotocin or alloxan injections or initiation of hypercholesterolaemic diet. In contrast, the current human data have been obtained from patients with longstanding risk factors and/or proven coronary artery disease and peripheral vascular disease [147, 148] . The vascular bed being studied may also have implications in inconsistent human results, namely, most of the studies carried out in human or animal conduit arteries have shown a beneficial effect while studies performed on human forearm i.e. microvessels have not revealed any beneficial effects [149, 150] .
Increased superoxide may however directly inactivate NO with the formation of the highly toxic oxidant, peroxynitrite. Endothelial dysfunction not only occurs in overt diabetes but can also be induced by simple exposure of isolated vessels to high glucose media in vitro [151] .
Pretreatment of rat aorta with SOD produces significantly greater relaxations in aortic rings incubated in high glucose [14] . Likewise pretreatment with SOD plus catalase or an inhibitor of hydroxyl radical formation (DETAPAC) has been shown to improve endothelial dysfunction in aortic rings of streptozotocin-induced diabetic rats suggesting that vascular production of both O 2 -and hydroxyl radicals may contribute to endothelial dysfunction in this model [152] . However, elevated ambient glucose concentrations in diabetes mellitus may result in glycosylation of native superoxide dismutase leading to impairment of its enzymatic activity [153] .
In addition, the changes in intracellular cell signalling may impair appropriate activation of NOS in response to neurohumoral or mechanical stimuli. Indeed, several recent studies strongly indicate the involvement of the pKC pathway in vascular complications in diabetes.
High concentrations of glucose strongly increase the intracellular levels of diacylglycerol which consequently lead to protein kinase C activation. In vitro hyperglycaemic endothelial dysfunction caused by incubation of vascular rings with high concentrations of glucose has been corrected with pKC inhibitors [154] . These in vitro observations have also been supported by in vivo studies demonstrating that therapy with pKC inhibitors ameliorated vascular complications in diabetic rats [112] . Although, the mechanisms underlying pKC- In recent years gene therapy studies have been conducted to reverse the immune-mediated destruction of the pancreatic beta cells in case of type I diabetes. Insulin gene delivered via a retroviral vector to the liver improved fasting glucose levels in streptozotocin-diabetic rats, but had little effect on glucose levels after feeding [159] . However, this approach is at present far from application in humans because physiologic regulation of insulin production and release in response to blood glucose levels over minutes has not yet been accomplished.
Conclusions
The 
